Global Human CYP2C19 Gene Polymorphism Detection Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Human CYP2C19 Gene Polymorphism Detection Kits market size was valued at US$ 17.3 million in 2024 and is forecast to a readjusted size of USD 30.5 million by 2031 with a CAGR of 8.5% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
The human CYP2C19 gene polymorphism detection kit is used to detect the two polymorphic sites of CYP2C19 gene G681A and G636A in human peripheral blood genomic DNA in vitro. The CYP2C19 gene has genetic diversity. CYP2C19*2 (G681A) and CYP2C19*3 (G636A) are the most common genetic variation types in the population, both of which cause enzyme activity loss, resulting in three phenotypes of rapid metabolism (EM), intermediate metabolism (IM) and slow metabolism (PM) in the population. Studies have shown that CYP2C19 is involved in the formation of active metabolites and intermediate metabolites of clopidogrel. The pharmacokinetics and antiplatelet effects of clopidogrel active metabolites vary with different CYP2C19 genotypes. After taking conventional doses of clopidogrel, patients with CYP2C19 slow metabolizers (PM) have reduced production of active metabolites in the body and reduced inhibitory effects on platelets. The human CYP2C19 gene polymorphism detection kit provides a reference for the clinical use of clopidogrel by detecting the two sites of human CYP2C19 gene G681A and G636A.
This report is a detailed and comprehensive analysis for global Human CYP2C19 Gene Polymorphism Detection Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human CYP2C19 Gene Polymorphism Detection Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human CYP2C19 Gene Polymorphism Detection Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Wuhan HealthCare Biotechnology, Beijing Biogench Biotechnology, Coyote Bioscience, Guangzhou Biotron Technology, Xiamen Zhishan Biological Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human CYP2C19 Gene Polymorphism Detection Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescence Quantitative PCR Method
Fluorescence PCR-enzyme Digestion Method
Market segment by Application
Hospital
Medical Research Institute
Others
Major players covered
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Wuhan HealthCare Biotechnology
Beijing Biogench Biotechnology
Coyote Bioscience
Guangzhou Biotron Technology
Xiamen Zhishan Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human CYP2C19 Gene Polymorphism Detection Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human CYP2C19 Gene Polymorphism Detection Kits, with price, sales quantity, revenue, and global market share of Human CYP2C19 Gene Polymorphism Detection Kits from 2020 to 2025.
Chapter 3, the Human CYP2C19 Gene Polymorphism Detection Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human CYP2C19 Gene Polymorphism Detection Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human CYP2C19 Gene Polymorphism Detection Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human CYP2C19 Gene Polymorphism Detection Kits.
Chapter 14 and 15, to describe Human CYP2C19 Gene Polymorphism Detection Kits sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
The human CYP2C19 gene polymorphism detection kit is used to detect the two polymorphic sites of CYP2C19 gene G681A and G636A in human peripheral blood genomic DNA in vitro. The CYP2C19 gene has genetic diversity. CYP2C19*2 (G681A) and CYP2C19*3 (G636A) are the most common genetic variation types in the population, both of which cause enzyme activity loss, resulting in three phenotypes of rapid metabolism (EM), intermediate metabolism (IM) and slow metabolism (PM) in the population. Studies have shown that CYP2C19 is involved in the formation of active metabolites and intermediate metabolites of clopidogrel. The pharmacokinetics and antiplatelet effects of clopidogrel active metabolites vary with different CYP2C19 genotypes. After taking conventional doses of clopidogrel, patients with CYP2C19 slow metabolizers (PM) have reduced production of active metabolites in the body and reduced inhibitory effects on platelets. The human CYP2C19 gene polymorphism detection kit provides a reference for the clinical use of clopidogrel by detecting the two sites of human CYP2C19 gene G681A and G636A.
This report is a detailed and comprehensive analysis for global Human CYP2C19 Gene Polymorphism Detection Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Human CYP2C19 Gene Polymorphism Detection Kits market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human CYP2C19 Gene Polymorphism Detection Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human CYP2C19 Gene Polymorphism Detection Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Wuhan HealthCare Biotechnology, Beijing Biogench Biotechnology, Coyote Bioscience, Guangzhou Biotron Technology, Xiamen Zhishan Biological Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human CYP2C19 Gene Polymorphism Detection Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fluorescence Quantitative PCR Method
Fluorescence PCR-enzyme Digestion Method
Market segment by Application
Hospital
Medical Research Institute
Others
Major players covered
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Wuhan HealthCare Biotechnology
Beijing Biogench Biotechnology
Coyote Bioscience
Guangzhou Biotron Technology
Xiamen Zhishan Biological Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human CYP2C19 Gene Polymorphism Detection Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human CYP2C19 Gene Polymorphism Detection Kits, with price, sales quantity, revenue, and global market share of Human CYP2C19 Gene Polymorphism Detection Kits from 2020 to 2025.
Chapter 3, the Human CYP2C19 Gene Polymorphism Detection Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human CYP2C19 Gene Polymorphism Detection Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human CYP2C19 Gene Polymorphism Detection Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human CYP2C19 Gene Polymorphism Detection Kits.
Chapter 14 and 15, to describe Human CYP2C19 Gene Polymorphism Detection Kits sales channel, distributors, customers, research findings and conclusion.
Table of Contents
88 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Human CYP2C19 Gene Polymorphism Detection Kits by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
